Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_assertion type Assertion NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_head.
- NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_assertion description "[We determined the cellular levels of EGF-R, IGF-II, and VEGF in the cervical cancer cell lines HeLa, ME-180 (both positive for human papilloma virus; HPV), and HT-3 (HPV-negative), following their treatment with IGF-BP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_provenance.
- NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_assertion evidence source_evidence_literature NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_provenance.
- NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_assertion SIO_000772 14599874 NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_provenance.
- NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_assertion wasDerivedFrom befree-20150227 NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_provenance.
- NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_assertion wasGeneratedBy ECO_0000203 NP368958.RAHLZ-V-jFkPJSPPJvdhpPD5p_bJ4Kz5gC4hnuu_j_HTo130_provenance.